Avalo Therapeutics (AVTX) Return on Capital Employed Growth (3y) (2018 - 2026)
Avalo Therapeutics (AVTX) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Avalo Therapeutics |
295.77 Mn |
295.77 Mn |
- |
13,766.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
13,766.00 |
| Dec 31, 2025 |
22,390.00 |
| Sep 30, 2025 |
23,028.00 |
| Jun 30, 2025 |
16,313.00 |
| Mar 31, 2025 |
9,993.00 |
| Dec 31, 2024 |
6,273.00 |
| Sep 30, 2024 |
-1,452.00 |
| Jun 30, 2024 |
-9,002.00 |
| Mar 31, 2024 |
30,065.00 |
| Dec 31, 2023 |
6,764.00 |
| Sep 30, 2023 |
-693.00 |
| Jun 30, 2023 |
-14,289.00 |
| Mar 31, 2023 |
-4,796.00 |
| Dec 31, 2022 |
-24,474.00 |
| Sep 30, 2022 |
-25,760.00 |
| Jun 30, 2022 |
-14,297.00 |
| Mar 31, 2022 |
-5,375.00 |
| Dec 31, 2021 |
-3,815.00 |
| Sep 30, 2021 |
-3,715.00 |
| Jun 30, 2021 |
-20,195.00 |
